Arvee Laboratories logo

Arvee Laboratories

ARVEE NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹205 Cr
Volatility
Moderate
P/E Ratio
49.23
EBITDA
₹3.19 Cr
Return on Equity
6.87%
Debt to Equity
0.03
Book Value
₹30.66
52W High
₹290.78
52W Low
₹129.11

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

6
  • Stock is trading at 5.89 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -7.83% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 5.88% over last 3 years.
  • Debtor days have increased from 91.4 to 121 days.

Growth Rate

Revenue Growth
-19.41% higher than 3Y
Net Income Growth
-2.38% higher than 3Y
Cash Flow Change
-106% higher than 3Y
ROE
90.3% higher than 3Y
ROCE
38.95% higher than 3Y
EBITDA Margin (Avg.)
-9.08% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
7.6
8.91
7.7
6.14
10.6
12.53
8.91
6.45
7.48
3.45
9.78
10.8
17.23
Expenses
6.62
8.22
7.17
5.35
9.06
11.03
8.57
6.23
7.14
3.33
8.15
9.7
14.74
Operating Profit
0.98
0.69
0.53
0.79
1.54
1.5
0.34
0.22
0.34
0.12
1.63
1.1
2.49
OPM %
12.89%
7.74%
6.88%
12.87%
14.53%
11.97%
3.82%
3.41%
4.55%
3.48%
16.67%
10.19%
14.45%
Other Income
0.09
0.09
0.19
0.21
0.11
0.16
0.19
0.21
0.17
0.23
0.14
0.15
0.18
Interest
0.07
0.08
0.05
0.05
0.08
0.05
0.05
0.07
0.04
0.04
0.07
0.08
0.06
Depreciation
0.35
0.42
0.35
0.37
0.31
0.3
0.28
0.27
0.29
0.3
0.3
0.31
0.32
PBT
0.65
0.28
0.32
0.58
1.26
1.31
0.2
0.09
0.18
0.01
1.4
0.86
2.29
Tax %
24.62%
25%
25%
81.03%
25.4%
25.19%
25%
22.22%
5.56%
0%
-30.71%
38.37%
26.2%
Net Profit
0.49
0.21
0.24
0.12
0.94
0.98
0.15
0.07
0.17
0.01
1.83
0.52
1.69
EPS in Rs
0.44
0.19
0.22
0.11
0.85
0.89
0.14
0.06
0.15
0.01
1.66
0.47
1.53
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
26.82
34.44
47.78
54.9
45.42
47.38
40.33
61.35
30.35
38.49
31.51
41.26
Expenses
21.83
28.54
40.61
48.73
39.4
41.31
34.65
54.06
27.41
34.88
28.33
35.92
Operating Profit
4.99
5.9
7.17
6.17
6.02
6.07
5.68
7.29
2.94
3.61
3.18
5.34
OPM %
18.61%
17.13%
15.01%
11.24%
13.25%
12.81%
14.08%
11.88%
9.69%
9.38%
10.09%
12.94%
Other Income
0.1
0.51
0.23
0.35
0.35
0.56
0.46
1.35
0.64
0.66
0.69
0.7
Interest
3.07
3.48
3.33
1.63
0.99
0.58
0.37
0.39
0.25
0.25
0.23
0.25
Depreciation
1.49
2.07
2.15
2.35
2.29
2.41
2.32
2.08
1.5
1.15
1.21
1.23
PBT
0.53
0.86
1.92
2.54
3.09
3.64
3.45
6.17
1.83
2.87
2.43
4.56
Tax %
66.04%
-81.4%
43.23%
11.02%
25.89%
26.37%
25.51%
33.23%
42.62%
25.09%
-3.7%
—
Net Profit
0.19
1.55
1.09
2.26
2.3
2.68
2.57
4.12
1.05
2.15
2.53
4.05
EPS in Rs
0.23
1.91
0.99
2.05
2.09
2.43
2.33
3.74
0.95
1.95
2.3
3.67
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.05
4.05
5.51
5.51
5.51
11.02
11.02
11.02
11.02
11.02
11.02
Reserves
-1.41
0.15
8.69
10.95
13.25
10.42
12.92
17.04
18.09
20.24
22.77
Borrowings
25.32
24.99
16.15
12.87
3.87
8.88
3.13
1
1
1.03
1.11
Other Liabilities
7.25
6.49
13.77
7.81
11
10.73
11.61
9.63
8.45
5.29
7.99
Total Liabilities
35.21
35.68
44.12
37.14
33.63
41.05
38.68
38.69
38.56
37.58
42.89
Fixed Assets
13.15
16.88
14.88
12.65
13.18
13.81
13.84
12.68
12.67
15.27
16.72
CWIP
4.3
0
1.18
2.32
1.78
0.97
0.98
1.53
2.62
0.73
0.9
Investments
0
0
0
1.95
3.09
2.03
0
0
0
0
1.7
Other Assets
17.76
18.8
28.06
20.22
15.58
24.24
23.86
24.48
23.27
21.58
23.57
Total Assets
35.21
35.68
44.12
37.14
33.63
41.05
38.68
38.69
38.56
37.58
42.89
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
4.03
6.02
9.46
10.31
1.71
0.68
2.93
3.66
-0.21
-0.12
Investing
—
-1.4
-1.23
-2.85
-3.08
-0.6
0.06
-1.26
-2.16
-1.32
0.5
Financing
—
-2.92
-3.78
-4.92
-9.9
4.52
-6.06
-2.42
-0.19
-0.12
-0.16
Net Cash Flow
—
-0.29
1
1.68
-2.67
5.63
-5.32
-0.75
1.31
-1.64
0.23
Free Cash Flow
—
2.54
4.68
7.96
8.02
-0.53
-1.68
1.47
1.07
-2.06
-2.95
CFO/OP
—
57
96
158
184
44
29
64
139
10
3
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82.61
87.12
118
52.66
52.4
60.7
110
72.94
73.48
79.66
121
Inventory Days
155
105
99.61
42.9
80.96
91.96
93.24
42.29
159
80.31
229
Days Payable
131
98.14
150
55.84
126
118
160
73.3
164
57.72
159
Cash Conversion Cycle
107
93.5
67.84
39.72
7.72
34.59
42.9
41.94
68.01
102
191
Working Capital Days
30.08
30.84
30.79
-6.52
10.29
-10.63
49.96
70.44
95.97
104
168
ROCE %
—
15.19%
17.64%
13.67%
14.9%
14.92%
12.89%
23.34%
6.83%
9.58%
7.53%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Arvee Laboratories insights

50 extracted metrics + investor summaries across FY16–FY26.

Log in — free

Shareholding Pattern

Promot.73.50%Others0.33%Public26.16%As ofJun 2026

Documents

Frequently Asked Questions about Arvee Laboratories

What does Arvee Laboratories (India) Ltd do?
Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]
Where is Arvee Laboratories (India) Ltd (ARVEE) listed?
Arvee Laboratories (India) Ltd trades as ARVEE on the NSE.
Which sector does Arvee Laboratories (India) Ltd belong to?
Arvee Laboratories (India) Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd has a market capitalisation of ₹205.09 Cr, which places it in the Small Cap band.
What is the PE ratio of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd trades at a PE ratio of 49.23, against a book value of ₹30.66 per share.
What is the 52-week high and low of Arvee Laboratories (India) Ltd?
Over the last 52 weeks Arvee Laboratories (India) Ltd has traded between ₹129.11 and ₹290.78.
What is the Return on Equity (ROE) of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd reported a return on equity of 6.87%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]

Website arveelabs.com
CEO Mr. Shalin Sudhakarbhai Patel
Employees 70
Listed 2021-03-22
Face Value ₹ 10
Issued Size 1,10,20,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ARVEE.md for Arvee Laboratories (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List